Phase iii studies of single-agent docetaxel in patients with metastatic breast cancer who have progressed despite previous chemotherapy regimens : Preliminary results: Docetaxel in the treatment of breast cancer

Journal article

Peer reviewed

Seminars in oncology, Vol.25(6), pp.4-9

1998

Abstract

Antineoplastic agents

Biological and medical sciences

Chemotherapy

Medical sciences

Pharmacology. Drug treatments

1 Record Views

Title: Phase iii studies of single-agent docetaxel in patients with metastatic breast cancer who have progressed despite previous chemotherapy regimens : Preliminary results
Creators - without role: J.-M Nabholtz - Cross Cancer Institute, Edmonton, Alberta, Canada
J Crown - Cross Cancer Institute, Edmonton, Alberta, Canada
Publication Details: Seminars in oncology, Vol.25(6), pp.4-9
Publisher: Elsevier
Identifiers: 9952875708331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article